HealthStream, Inc. (HSTM) vs Rigel Pharmaceuticals, Inc. (RIGL)
A side-by-side comparison of HealthStream, Inc. and Rigel Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HSTM
HealthStream, Inc.
$31.30HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
RIGL
Rigel Pharmaceuticals, Inc.
$46.50HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT
Total return — HSTM vs RIGL
growth of $100 · dividends reinvested · last 10yHSTM +19.7% (+1.8%/yr)RIGL +26.8% (+2.4%/yr)RIGL compounded faster over this window
HSTM RIGL
HSTM vs RIGL: by the numbers
- •HSTM is the larger company ($914M vs $860M market cap).
- •RIGL trades at the lower trailing earnings multiple (2.85 vs 43.76 P/E), one valuation lens rather than an overall verdict.
- •RIGL converts more revenue to profit (116.30% vs 6.60% net margin).
- •RIGL grew revenue faster over the past five years (13.94% vs 5.05% CAGR).
- •HSTM pays a dividend (0.43% yield), while RIGL has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | HSTM | RIGL |
|---|---|---|
| P/E ratio | 43.76 | 2.85 |
| Forward P/E | 42.41 | 13.56 |
| PEG ratio | 6.48 | N/A |
| P/S ratio | 2.85 | 3.11 |
| P/B ratio | 2.56 | 2.02 |
| EV / EBITDA | 12.54 | 9.36 |
| FCF yield | 5.34% | 9.23% |
Profitability
| Metric | HSTM | RIGL |
|---|---|---|
| Gross margin | 65.08% | 91.39% |
| Operating margin | 8.04% | 42.63% |
| Net margin | 6.60% | 116.30% |
| ROE | 5.94% | 75.67% |
| ROIC | 4.96% | 18.72% |
Dividends
| Metric | HSTM | RIGL |
|---|---|---|
| Dividend yield | 0.43% | N/A |
| Payout ratio | 19.01% | N/A |
Growth (annualized)
| Metric | HSTM | RIGL |
|---|---|---|
| Revenue CAGR (5Y) | 5.05% | 13.94% |
| EPS CAGR (5Y) | 6.75% | N/A |
| FCF CAGR (5Y) | 2.33% | N/A |
| Total return CAGR (5Y) | 2.34% | 6.25% |
Frequently asked
- Which has the lower trailing P/E, HSTM or RIGL?
- RIGL has the lower trailing P/E: HSTM trades at 43.76 and RIGL at 2.85. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, HSTM or RIGL?
- Over the past five years, RIGL grew revenue faster — HSTM at a 5.05% CAGR versus RIGL at 13.94%.
- Does HSTM or RIGL pay a bigger dividend?
- HSTM pays a dividend (0.43% yield), while RIGL has no payments in the available dividend history.
- Is HSTM or RIGL more profitable?
- RIGL runs the higher net margin — HSTM at 6.60% versus RIGL at 116.30%.
- How have HSTM and RIGL total returns compared?
- Over the past 10 years, HSTM delivered 1.25% and RIGL delivered 1.77% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
HealthStream P/E ratioRigel Pharmaceuticals P/E ratioHealthStream dividend yieldHealthStream ROERigel Pharmaceuticals ROEHealthStream operating marginRigel Pharmaceuticals operating marginHealthStream revenue growthRigel Pharmaceuticals revenue growthHealthStream free cash flowRigel Pharmaceuticals free cash flow
HealthStream & Rigel Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.